Busulfan Treatment for Myeloproliferative Disease may Reduce Injection Burden in Vascular Endothelial Growth Factor-Driven Retinopathy

PURPOSE: Myeloproliferative neoplasms (MPNs) have been associated with increased systemic levels of vascular endothelial growth factor (VEGF). This study investigated an association between systemic busulfan for treatment of MPN and the requirement for intravitreal anti-VEGF injections for treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Dalvin, Lauren A., Olsen, Timothy W., Bakri, Sophie J., McCullough, Kristen, Tefferi, Ayalew, Al-Kali, Aref
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Image
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058582/
https://www.ncbi.nlm.nih.gov/pubmed/35509281
http://dx.doi.org/10.1016/j.ajoc.2022.101554

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058582/
https://www.ncbi.nlm.nih.gov/pubmed/35509281
http://dx.doi.org/10.1016/j.ajoc.2022.101554

Ejemplares similares